During the past decade, Sankt Gertrauden-Krankenhaus conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sankt Gertrauden-Krankenhaus" #1 sponsor was "Contego Medical, Inc." with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "B. Braun Melsungen AG" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sankt Gertrauden-Krankenhaus" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator, "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Sankt Gertrauden-Krankenhaus" are "Breast Cancer" (2 trials), "Peripheral Arterial Disease" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Arteriosclerosis" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Sankt Gertrauden-Krankenhaus" in a lesser frequency.

Most popular intervention types in "Sankt Gertrauden-Krankenhaus" are "Device" (8 trials), "Drug" (4 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Evia/Entovis pacemaker system under Magnetic Resonance Imaging (MRI) conditions" (1 trials), "External beam radiotherapy" (1 trials), "Gemcitabine" (1 trials) and "JETi Peripheral Thrombectomy System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sankt Gertrauden-Krankenhaus" are 8 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sankt Gertrauden-Krankenhaus". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sankt Gertrauden-Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sankt Gertrauden-Krankenhaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".